Muestra la distribución de disciplinas para esta publicación.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
Indexado |
|
||||
DOI | |||||
Año | 1997 | ||||
Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background: Intersphincteric injection of botulinum toxin (BoTx) has demonstrated to be effective in the short-term treatment of achalasia. Aim: To assess the efficacy, safety and long-term outcome of BoTx injection into the lower esophageal sphincter (LES) of patients with achalasia. Patients and methods: Eight patients received 80 units of BoTx. Assessment of response was based on changes in the symptom scores (0-9) and esophageal manometric studies. Results: Six out of 8 patients (75%) had sustained clinical improvement after therapy. This effect was maintained for a mean time of 17.8 months. The symptom score decreased from a mean of 6,7 to 0,5 (p < 0.01) and after treatment, LES pressure decreased from 63 to 25.5 mm Hg (p = 0.07). There were no serious adverse effects. Five of the six responders have relapsed. Two of these patients received a second BoTx injection with satisfactory results, two went to surgery and one refused other type of therapy and died of pneumonia. Conclusions: Intersphincteric BoTx injection is a simple, safe and effective method of treatment in patients with achalasia, with a duration of response averaging 1,5 years. Its use may be suggested in some patients with high surgical risk and those who refuse a more invasive therapy. It is also useful in malnourished patients to attain an adequate nutritional status before surgery.
Ord. | Autor | Género | Institución - País |
---|---|---|---|
1 | Zapata, R | - | |
2 | Carvajal, Sebastián | Hombre | |
3 | Alvarez, M | - | |
4 | Gonzalez, R | - | |
5 | CHIANALE-BERTOLINI, JOSE LUIS | Hombre | |
6 | ROLLAN-RODRIGUEZ, ANTONIO RAFAEL | Hombre |